A 4-year Follow-up Study of Syndromal and Sub-syndromal Anxiety and Depression Symptoms in the General Population: the HUNT Study
Overview
Affiliations
Background: Our aims were to examine the stability of self-rated anxiety and depression symptoms and the predictors for change in case-level status after 4 years in a general population sample.
Methods: Prospective cohort study. Based on the total score on the Hospital Anxiety and Depression rating scale (HADS-T) in HUNT 2 (1995-1997), three groups were identified: Level 3 (n = 654, score >or= 25 points), Level 2 (n = 654, score 19-24 points), and Level 1 (n = 1,308, score < 19 points). The groups were followed up with a mailed questionnaire after 4 years.
Results: Among the 1,326 (53% response rate) who participated in the follow-up, 816 (62%) had not changed symptom level. The number of participants that had crossed the HADS-T caseness level (19 points) was the same in both directions. In non-cases at baseline (Level 1), lack of friends (OR 2.34, 95% CI 1.28-4.27, P = 0.006) and previous episodes of depression (OR 2.90, 95% CI 1.76-4.78, P < 0.001) predicted HADS-T caseness at follow-up, while higher educational level (OR 0.66, 95% CI 0.46-0.96, P = 0.028) protected from developing caseness level of anxiety and depression. In HADS-T cases (Levels 2 and 3) at baseline, previous episode(s) of depression (OR 0.36, 95% CI 0.19-0.68, P = 0.002) and being unemployed (OR 0.58, 95% CI 0.34-1.00, P = 0.050) predicted HADS-T caseness at follow-up, whereas a higher educational level (OR 1.83, 95% CI 1.24-2.70, P = 0.002) was associated with remission from HADS-T caseness after 4 years.
Conclusions: Though symptom fluctuation was considerable, conventional HADS-T caseness (>or=19 points) was a reliable and valid predictor for high long-term symptom stability of anxiety and depression in our general population sample.
Allen R, Hochard K, Kannangara C, Carson J Behav Sci (Basel). 2025; 14(12.
PMID: 39767287 PMC: 11673234. DOI: 10.3390/bs14121146.
Tonti S, Marzolini B, Bulgheroni M JMIR Biomed Eng. 2024; 6(2):e15417.
PMID: 38907377 PMC: 11041439. DOI: 10.2196/15417.
Sorensen A, Bager P, Nielsen N, Koch A, Spiliopoulos L, Hviid A BMJ Open. 2024; 14(5):e087799.
PMID: 38719312 PMC: 11085694. DOI: 10.1136/bmjopen-2024-087799.
Schertel Cassiano L, Peres M, Motta J, Demarco F, Horta B, Ribeiro C Nutrients. 2022; 14(18).
PMID: 36145111 PMC: 9503140. DOI: 10.3390/nu14183735.
Naiditch N, Billot M, Goudman L, Cornet P, Roulaud M, Ounajim A J Clin Med. 2021; 10(21).
PMID: 34768575 PMC: 8584436. DOI: 10.3390/jcm10215055.